CDKN2A and telomere syndrome: In the TCGA sarcoma cohort dataset, our analyses did not show any significant relationship between CDKN2A and PIK3R1 expression and survival, suggesting that these two genes are unlikely prognostic factors in STS and potentially might be involved in response to the treatment in this case series.